| | | | | | | | | | | | | Just Released: 2025 NLN Position Paper The National Lymphedema Network is pleased to announce the release of its updated Position Statement on Lymphedema Diagnosis and Treatment. | | | | | | | | | | | | | | | Why It Matters This updated paper reflects over a decade of clinical advancements and provides guidance on: - Diagnostic criteria for primary and secondary lymphedema
- Prospective surveillance and early intervention
- Objective measurement tools and outcome sets
- Updated imaging and staging recommendations
It builds a unified foundation for clinicians, researchers, and educators working across lymphatic care. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Read the Full Paper Download the full position statement to explore key insights and current best practices developed by the NLN Medical Advisory Committee. | | | | | | | | | | | | | | | | Hear It Live in Nashville Dr. David Doubblestein, PT, PhD, OCS, CLT-LANA, Cert, MDT, LLCC will present this paper during the 2025 NLN Conference, taking place September 19–21 at Belmont University in Nashville. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | National Lymphedema Network 2229 Bridge Avenue #667 Point Pleasant, NJ 08742 (800) 541-3259 If you would like to unsubscribe: please click here | | | | | | | | | | | Copyright © 2025 National Lymphedema Network, All rights reserved. | | | | | | | | | | | | | | | | | | | |